BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11845389)

  • 1. [Immunity against prions?].
    Heppner FL; Aguzzi A
    Dtsch Med Wochenschr; 2002 Feb; 127(7):328-30. PubMed ID: 11845389
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity against prions?
    Heppner FL; Arrighi I; Kalinke U; Aguzzi A
    Trends Mol Med; 2001 Nov; 7(11):477-9. PubMed ID: 11689311
    [No Abstract]   [Full Text] [Related]  

  • 3. PrP expression in B lymphocytes is not required for prion neuroinvasion.
    Klein MA; Frigg R; Raeber AJ; Flechsig E; Hegyi I; Zinkernagel RM; Weissmann C; Aguzzi A
    Nat Med; 1998 Dec; 4(12):1429-33. PubMed ID: 9846583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infectious proteins or prions. A new mechanism of disease].
    Benítez-Bribiesca L
    Gac Med Mex; 1998; 134(1):107-9. PubMed ID: 9658704
    [No Abstract]   [Full Text] [Related]  

  • 5. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A crucial role for B cells in neuroinvasive scrapie.
    Klein MA; Frigg R; Flechsig E; Raeber AJ; Kalinke U; Bluethmann H; Bootz F; Suter M; Zinkernagel RM; Aguzzi A
    Nature; 1997 Dec 18-25; 390(6661):687-90. PubMed ID: 9414161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunological approach to prion diseases.
    Paraf A
    Med Hypotheses; 1998 Jan; 50(1):85-90. PubMed ID: 9488187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What are the prions?].
    Piédrola Angulo G
    An R Acad Nac Med (Madr); 2001; 118(3):599-604. PubMed ID: 11783039
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-prion antibodies for prophylaxis following prion exposure in mice.
    Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
    Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
    Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.
    Piccardo P; Langeveld JP; Hill AF; Dlouhy SR; Young K; Giaccone G; Rossi G; Bugiani M; Bugiani O; Meloen RH; Collinge J; Tagliavini F; Ghetti B
    Am J Pathol; 1998 Jun; 152(6):1415-20. PubMed ID: 9626045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could immunomodulation be used to prevent prion diseases?
    Wisniewski T; Goñi F
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):307-17. PubMed ID: 22397565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocytes and neuroinvasion.
    Brown P
    Nature; 1997 Dec 18-25; 390(6661):662-3. PubMed ID: 9414158
    [No Abstract]   [Full Text] [Related]  

  • 15. A brief overview of bovine spongiform encephalopathy and related diseases including a TSE risk analysis of bovine starting materials used during the manufacture of vaccines for use in humans.
    Bradley R
    Przegl Epidemiol; 2001; 55(3):387-405. PubMed ID: 11761847
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.
    Heppner FL; Musahl C; Arrighi I; Klein MA; Rülicke T; Oesch B; Zinkernagel RM; Kalinke U; Aguzzi A
    Science; 2001 Oct; 294(5540):178-82. PubMed ID: 11546838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
    Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
    J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spongiform diseases. After the crisis: more questions about prions.
    Enserink M
    Science; 2005 Dec; 310(5755):1756-8. PubMed ID: 16357237
    [No Abstract]   [Full Text] [Related]  

  • 19. Creutzfeldt-Jakob disease and transplantation: facts and fables.
    Dormont D
    Transplant Proc; 1996 Oct; 28(5):2931-3. PubMed ID: 8908129
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent developments in mucosal vaccines against prion diseases.
    Sakaguchi S; Arakawa T
    Expert Rev Vaccines; 2007 Feb; 6(1):75-85. PubMed ID: 17280480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.